Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)

ClinicalTrials.gov ID: NCT02908035

Public ClinicalTrials.gov record NCT02908035. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 1:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

TANGO: Temsirolimus Adventitial Delivery to Improve ANGiographic Outcomes Below the Knee

Study identification

NCT ID
NCT02908035
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mercator MedSystems, Inc.
Industry
Enrollment
100 participants

Conditions and interventions

Interventions

  • Temsirolimus Drug
  • Saline Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2, 2017
Primary completion
Aug 31, 2020
Completion
Aug 31, 2021
Last update posted
Jun 10, 2020

2017 – 2021

United States locations

U.S. sites
8
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
Arkansas Heart Hospital Little Rock Arkansas 72211
St. Joseph Hospital of Orange Heart and Vascular Center Orange California 92868
Denver Veterans Administration Hospital Denver Colorado 80220
Advocate Christ Medical Center Oak Lawn Illinois 60453
University Hospital Cleveland Ohio 44106
Einstein Medical Center Philadelphia Pennsylvania 19141
Sanford Research Sioux Falls South Dakota 57101
Baylor College of Medicine Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02908035, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 10, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02908035 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →